Molecular Genetic Characterization of Individual Cancer Cells Isolated via Single-Cell Printing

Intratumoral genetic heterogeneity may impact disease outcome. Gold standard for dissecting clonal heterogeneity are single-cell analyses. Here, we present an efficient workflow based on an advanced Single-Cell Printer (SCP) device for the study of gene variants in single cancer cells. To allow for precise cell deposition into microwells the SCP was equipped with an automatic dispenser offset compensation, and the 384-microwell plates were electrostatically neutralized. The ejection efficiency was 99.7% for fluorescent beads (n = 2304) and 98.7% for human cells (U-2 OS or Kasumi-1 cancer cell line, acute myeloid leukemia [AML] patient; n = 150). Per fluorescence microscopy, 98.8% of beads were correctly delivered into the wells. A subset of single cells (n = 81) was subjected to whole genome amplification (WGA), which was successful in all cells. On empty droplets, a PCR on LINE1 retrotransposons yielded no product after WGA, verifying the absence of free-floating DNA in SCP-generated droplets. Representative gene variants identified in bulk specimens were sequenced in single-cell WGA DNA. In U-2 OS, 22 of 25 cells yielded results for both an SLC34A2 and TET2 mutation site, including cells harboring the SLC34A2 but not the TET2 mutation. In one cell, the TET2 mutation analysis was inconclusive due to allelic dropout, as assessed via polymorphisms located close to the mutation. Of Kasumi-1, 23 of 33 cells with data on both the KIT and TP53 mutation site harbored both mutations. In the AML patient, 21 of 23 cells were informative for a TP53 polymorphism; the identified alleles matched the loss of chromosome arm 17p. The advanced SCP allows efficient, precise and gentle isolation of individual cells for subsequent WGA and routine PCR/sequencing-based analyses of gene variants. This makes single-cell information readily accessible to a wide range of applications and can provide insights into clonal heterogeneity that were indeterminable solely by analyses of bulk specimens.

[1]  W. Hiddemann,et al.  Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. , 2016, Blood.

[2]  S. Ogawa,et al.  Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesis. , 2016, Leukemia research.

[3]  Wei Zhang,et al.  Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling , 2016, Tumor Biology.

[4]  K. Inokuchi,et al.  Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia , 2016, Leukemia.

[5]  Ramesh Ramakrishnan,et al.  Single-Cell Genetic Analysis Using Automated Microfluidics to Resolve Somatic Mosaicism , 2015, PloS one.

[6]  Roland Zengerle,et al.  Technologies for Single-Cell Isolation , 2015, International journal of molecular sciences.

[7]  P Koltay,et al.  Single-cell PCR of genomic DNA enabled by automated single-cell printing for cell isolation. , 2015, Biosensors & bioelectronics.

[8]  Paul Polakis,et al.  Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody–Drug Conjugate as a Therapeutic for Non–Small Cell Lung and Ovarian Cancers , 2015, Clinical Cancer Research.

[9]  J. Teruya-Feldstein,et al.  FoxO1-Dependent Induction of Acute Myeloid Leukemia by Osteoblasts in Mice , 2015, Leukemia.

[10]  Loren J. Martin,et al.  The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors , 2015, Science Translational Medicine.

[11]  J. Radich,et al.  Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia , 2015, Science Translational Medicine.

[12]  W. Koh,et al.  Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics , 2014, Proceedings of the National Academy of Sciences.

[13]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[14]  N. Navin.  Cancer genomics: one cell at a time , 2014, Genome Biology.

[15]  N. Navin,et al.  Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing , 2014, Nature.

[16]  Christopher A. Miller,et al.  Clonal Architecture of Secondary Acute Myeloid Leukemia Defined by Single-Cell Sequencing , 2014, PLoS genetics.

[17]  Jian Wang,et al.  Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing , 2014, Cell Research.

[18]  Christopher A. Miller,et al.  Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. , 2014, Cancer cell.

[19]  I. Amit,et al.  Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell Types , 2014, Science.

[20]  Mark J. Ratain,et al.  Tumour heterogeneity in the clinic , 2013, Nature.

[21]  Dong Sung Kim,et al.  Spontaneous electrical charging of droplets by conventional pipetting , 2013, Scientific Reports.

[22]  T. Trikalinos,et al.  Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. , 2013, American journal of epidemiology.

[23]  K. Hemminki,et al.  Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. , 2012, Mutagenesis.

[24]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[25]  A. Hagemeijer,et al.  Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.

[26]  M. Lübbert,et al.  Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the ‘second hit’ hypothesis , 2008, Leukemia.

[27]  M. Murphy,et al.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential , 2003, Nature Genetics.

[28]  S. Kingsmore,et al.  Comprehensive human genome amplification using multiple displacement amplification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Larizza,et al.  Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia. , 2002, The hematology journal : the official journal of the European Haematology Association.